- Home
- RRGB vs ALGS Comparison
RRGB vs ALGS Comparison
Compare RRGB & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRGB
- ALGS
- Stock Information
- Founded
- RRGB 1969
- ALGS 2018
- Country
- RRGB United States
- ALGS United States
- Employees
- RRGB N/A
- ALGS N/A
- Industry
- RRGB Restaurants
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- RRGB Consumer Discretionary
- ALGS Health Care
- Exchange
- RRGB Nasdaq
- ALGS Nasdaq
- Market Cap
- RRGB 88.7M
- ALGS 72.6M
- IPO Year
- RRGB 2002
- ALGS 2020
- Fundamental
- Price
- RRGB $6.52
- ALGS $9.89
- Analyst Decision
- RRGB Strong Buy
- ALGS Strong Buy
- Analyst Count
- RRGB 2
- ALGS 2
- Target Price
- RRGB $11.00
- ALGS $60.00
- AVG Volume (30 Days)
- RRGB 209.5K
- ALGS 94.1K
- Earning Date
- RRGB 11-05-2025
- ALGS 11-06-2025
- Dividend Yield
- RRGB N/A
- ALGS N/A
- EPS Growth
- RRGB N/A
- ALGS N/A
- EPS
- RRGB N/A
- ALGS N/A
- Revenue
- RRGB $1,235,920,000.00
- ALGS $3,174,000.00
- Revenue This Year
- RRGB N/A
- ALGS N/A
- Revenue Next Year
- RRGB N/A
- ALGS N/A
- P/E Ratio
- RRGB N/A
- ALGS N/A
- Revenue Growth
- RRGB N/A
- ALGS N/A
- 52 Week Low
- RRGB $2.50
- ALGS $3.76
- 52 Week High
- RRGB $7.89
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- RRGB 46.04
- ALGS 48.98
- Support Level
- RRGB $6.37
- ALGS $9.79
- Resistance Level
- RRGB $6.99
- ALGS $10.89
- Average True Range (ATR)
- RRGB 0.31
- ALGS 0.74
- MACD
- RRGB -0.07
- ALGS 0.02
- Stochastic Oscillator
- RRGB 15.23
- ALGS 39.68
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.